Zobrazeno 1 - 10
of 530
pro vyhledávání: '"AKIRA KITABATAKE"'
Autor:
Hiroshi Otani, Subrina Jesmin, Hiroko Togashi, Ichiro Sakuma, Kunihiko Nakai, Hiroshi Satoh, Mitsuhiro Yoshioka, Akira Kitabatake
Publikováno v:
Journal of Pharmacological Sciences, Vol 96, Iss 2, Pp 188-198 (2004)
Evidence suggests that S-nitrosylation is a biological process involved in cerebral ischemia. The aim of the present study was to elucidate the effects of S-nitrosylated (SNO) polyethylene glycol-conjugated (PEG) hemoglobin (Hb) developed as an artif
Externí odkaz:
https://doaj.org/article/01820efe928a4cdaae0bc7c0c6f22b53
Publikováno v:
Circulation Reports
Background: Heart rate (HR) reduction by β-blocker might not benefit patients with heart failure and reduced ejection fraction (HFrEF) with atrial fibrillation (AF). Methods and Results: The J-CHF study was a prospective randomized multicenter trial
Publikováno v:
Circulation Journal. 82:691-698
BACKGROUND Anemia portends a poor clinical outcome in patients with chronic heart failure (CHF). However, its mechanism remains unknown. We sought to elucidate the effect of anemia on patients with HF with reduced ejection fraction (HFrEF) who receiv
Autor:
Masayoshi Mishima, Tohru Masuyama, Shoichi Senda, Akira Kitabatake, Michitoshi Inoue, Jun Tanouchi, Yoshifumi Sakurai, Hisaki Morita, Masatsugu Hori, Masato Asao, Hirohide Matsuo, Kunihiro Chihara, Hiroshi Abe
Publikováno v:
Clinical Hemorheology and Microcirculation. 2:85-91
Publikováno v:
Journal of Cardiac Failure. 21:198-207
Background Autoantibody against β 1 -adrenergic receptors (β 1 -AAb) exerts agonist-like action inducing receptor uncoupling and myocardial damage. We attempted to determine the significance of β 1 -AAb in chronic heart failure (CHF) patients who
Autor:
Akihiko Hanaoka, Mikio Izumi, Kaoru Komuro, Tsuyoshi Mitake, Di Wu, Satoshi Yamada, Taisei Mikami, Keiko Nishihara, Hisao Onozuka, Akira Kitabatake, Naohiro Yoshida, Satoshi Fujii
Publikováno v:
Journal of medical ultrasonics (2001). 30(3)
We recently developed a wideband 15-MHz linear array probe (15 M) with a band width of 8 MHz (9–17 MHz). Both axial and lateral resolution of 15 M, evaluated using a phantom model, were better than those of the current 10-MHz linear probe. To compa
Autor:
Toshiie Sakata, Yuji Matsuzawa, Hitoshi Hishida, Akira Kitabatake, Hiroshige Itakura, Shinichi Oikawa, Toru Kita, Yasushi Saito, Noriaki Nakaya, Yuichi Ishikawa, Masunori Matsuzaki, Kunio Shirato, Jun Sasaki, Kazuyuki Shimada, Hideki Origasa, Mitsuhiro Yokoyama
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 19:673-679
Aim: The Japan EPA Lipid Intervention Study (JELIS) reported a 19% reduction of the risk for coronary artery disease after long-term use of pure eicosapentaenoic acid (EPA) in Japanese patients with hypercholesterolemia. The variation in plasma fatty
Autor:
Toshiie Sakata, Jun Sasaki, Hideki Origasa, Mitsuhiro Yokoyama, Yasushi Saito, Akira Kitabatake, Hitoshi Hishida, Kazuyuki Shimada, Yuji Matsuzawa, Kunio Shirato, Noriaki Nakaya, Shinichi Oikawa, Toru Kita, Hiroshige Itakura, Yuichi Ishikawa, Masunori Matsuzaki
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 18:99-107
Aim: The Japan EPA Lipid Intervention Study (JELIS) was the first prospective randomized clinical trial to demonstrate prevention of coronary events by pure eicosapentaenoic acid (EPA). The aim of this study was to examine the relationships between v
Autor:
Yuichi Ishikawa, Mitsuhiro Yokoyama, Yasushi Saito, Masunori Matsuzaki, Hideki Origasa, Shinichi Oikawa, Jun Sasaki, Hitoshi Hishida, Hiroshige Itakura, Toru Kita, Akira Kitabatake, Noriaki Nakaya, Toshiie Sakata, Kazuyuki Shimada, Kunio Shirato, Yuji Matsuzawa, null The JELIS Investigators
Publikováno v:
Circulation Journal. 74:1451-1457
Background: The JELIS trial examined the preventive effects of eicosapentaenoic acid (EPA) on coronary artery disease (CAD) in hypercholesterolemia. Previous investigators have reported that patients with peripheral artery disease (PAD) have a poor p